Adverse effects of the use of terlipressin infusion compared to boluses in patients with liver cirrhosis and variceal hemorrhage. TERMEX study.
Introduction and Objectives: Cirrhosis is a worldwide health problem as it is a leading cause of mortality. The development of complications in cirrhosis is directly related to the presence of portal hypertension. The risk of annual variceal hemorrhage is 5% for small varices and 15% for large varic...
Saved in:
| Main Authors: | Luis R. Antuna-Villaseñor, Germán A. Roman-Lugo, Jose Pérez-Sánchez, Alexis E. Chavarín-Meza, Yvonne Tadeo-Jiménez, Rosalba Moreno-Alcántar, Aleida Bautista-Santos |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-04-01
|
| Series: | Annals of Hepatology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268125000572 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hyponatraemia Induced by Terlipressin in Patients Diagnosed with Decompensated Liver Cirrhosis and Acute Variceal Bleeding
by: Mahmoud Elshehawy, et al.
Published: (2025-03-01) -
Baseline Renal Function Predicts Hyponatremia in Liver Cirrhosis Patients Treated with Terlipressin for Variceal Bleeding
by: Sung Eun Kim, et al.
Published: (2017-01-01) -
Safety, Tolerability, Pharmacokinetics, and Efficacy of Terlipressin Delivered by Continuous Intravenous Infusion in Patients with Cirrhosis and Refractory Ascites
by: Jasmohan S. Bajaj, et al.
Published: (2022-01-01) -
Terlipressin at esophageal varicose bleeding at liver cirrhosis with portal hypertension syndrome
by: B. N. Kotiv, et al.
Published: (2013-10-01) -
Response to L-ornitine L-aspartate in a single intravenous dose in cirrhotic patients with overt hepatic encephalopathy.
by: Yvonne Tadeo-Jiménez, et al.
Published: (2025-04-01)